Sebia SA:企業の製品パイプライン分析2018

◆英語タイトル:Sebia SA - Product Pipeline Analysis, 2018 Update
◆商品コード:DATA904C12189
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD1,500 ⇒換算¥222,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD2,250 ⇒換算¥333,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Sebia SA (Sebia) is a medical device company that designs, manufactures, commercializes, and exports electrophoresis tests and analyzers. The company’s electrophoresis program offers automated system for capillary electrophoresis, gel electrophoresis and electrophoresis scanning software. It also provides scientific and technical assistance services. Sebia offers automated system for capillary electrophoresis products such as capillarys 2 flex piercing, capillarys hr, neurosoft and minicap protein 6, among others. The company’s products are used in treatment of multiple myeloma, diabetes, hemoglobin disorders, alcoholisim, and others. It serves medical laboratories across France. Sebia is headquartered at Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Sebia SA
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Sebia SA Company Overview 5
Sebia SA Company Snapshot 5
Sebia SA Pipeline Products and Ongoing Clinical Trials Overview 5
Sebia SA – Pipeline Analysis Overview 8
Sebia SA – Key Facts 8
Sebia SA – Major Products and Services 9
Sebia SA Pipeline Products by Development Stage 11
Sebia SA Pipeline Products Overview 13
Capillarys 3 Octa Analyzer 13
Capillarys 3 Octa Analyzer Product Overview 13
Capillarys 3 Tera – CDT Assay 14
Capillarys 3 Tera – CDT Assay Product Overview 14
Capillarys 3 Tera – HbA1c Capillary Blood Assay 15
Capillarys 3 Tera – HbA1c Capillary Blood Assay Product Overview 15
Capillarys 3 Tera – Hemoglobin Adult Guthrie Assay 16
Capillarys 3 Tera – Hemoglobin Adult Guthrie Assay Product Overview 16
Capillarys 3 Tera – Hemoglobin Neonatal Cord Blood Assay 17
Capillarys 3 Tera – Hemoglobin Neonatal Cord Blood Assay Product Overview 17
Capillarys 3 Tera – Hemoglobin Neonatal Guthrie Assay 18
Capillarys 3 Tera – Hemoglobin Neonatal Guthrie Assay Product Overview 18
Capillarys 3 Tera – Hemoglobin Whole Blood Assay 19
Capillarys 3 Tera – Hemoglobin Whole Blood Assay Product Overview 19
Capillarys 3 Tera Assay – Protein HR 20
Capillarys 3 Tera Assay – Protein HR Product Overview 20
Capillarys 3 Tera Assay – Urine 21
Capillarys 3 Tera Assay – Urine Product Overview 21
Capillarys 3 Tera Assay – Urine IT 22
Capillarys 3 Tera Assay – Urine IT Product Overview 22
Capillarys 3 Tera MC Analyzer 23
Capillarys 3 Tera MC Analyzer Product Overview 23
CAPILLARYS 3 TERA TLA Analyzer 24
CAPILLARYS 3 TERA TLA Analyzer Product Overview 24
Diagnostic Test – Haemoglobin Diseases 25
Diagnostic Test – Haemoglobin Diseases Product Overview 25
Hydrashift 2/4 Daratumumab Assay 26
Hydrashift 2/4 Daratumumab Assay Product Overview 26
Sebia SA – Key Competitors 27
Sebia SA – Key Employees 28
Sebia SA – Locations And Subsidiaries 29
Head Office 29
Other Locations & Subsidiaries 29
Recent Developments 30
Sebia SA, Recent Developments 30
Jan 24, 2018: Sebia Announces FDA Clearance for its Hydrashift 2/4 daratumumab assay 30
Jun 10, 2015: Sebia brings to market new Capillarys 3 Tera automated system with CE mark HbA1c and serum protein testing, and immunotyping 30
Jan 09, 2013: Sebia Receives FDA 510(k) Clearance For Capillarys Hb A1c Kit 31
Appendix 32
Methodology 32
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Sebia SA Pipeline Products and Ongoing Clinical Trials Overview 5
Sebia SA Pipeline Products by Equipment Type 6
Sebia SA Pipeline Products by Indication 7
Sebia SA, Key Facts 8
Sebia SA, Major Products and Services 9
Sebia SA Number of Pipeline Products by Development Stage 11
Sebia SA Pipeline Products Summary by Development Stage 12
Capillarys 3 Octa Analyzer - Product Status 13
Capillarys 3 Octa Analyzer - Product Description 13
Capillarys 3 Tera - CDT Assay - Product Status 14
Capillarys 3 Tera - CDT Assay - Product Description 14
Capillarys 3 Tera - HbA1c Capillary Blood Assay - Product Status 15
Capillarys 3 Tera - HbA1c Capillary Blood Assay - Product Description 15
Capillarys 3 Tera - Hemoglobin Adult Guthrie Assay - Product Status 16
Capillarys 3 Tera - Hemoglobin Adult Guthrie Assay - Product Description 16
Capillarys 3 Tera - Hemoglobin Neonatal Cord Blood Assay - Product Status 17
Capillarys 3 Tera - Hemoglobin Neonatal Cord Blood Assay - Product Description 17
Capillarys 3 Tera - Hemoglobin Neonatal Guthrie Assay - Product Status 18
Capillarys 3 Tera - Hemoglobin Neonatal Guthrie Assay - Product Description 18
Capillarys 3 Tera - Hemoglobin Whole Blood Assay - Product Status 19
Capillarys 3 Tera - Hemoglobin Whole Blood Assay - Product Description 19
Capillarys 3 Tera Assay - Protein HR - Product Status 20
Capillarys 3 Tera Assay - Protein HR - Product Description 20
Capillarys 3 Tera Assay - Urine - Product Status 21
Capillarys 3 Tera Assay - Urine - Product Description 21
Capillarys 3 Tera Assay - Urine IT - Product Status 22
Capillarys 3 Tera Assay - Urine IT - Product Description 22
Capillarys 3 Tera MC Analyzer - Product Status 23
Capillarys 3 Tera MC Analyzer - Product Description 23
CAPILLARYS 3 TERA TLA Analyzer - Product Status 24
CAPILLARYS 3 TERA TLA Analyzer - Product Description 24
Diagnostic Test - Haemoglobin Diseases - Product Status 25
Diagnostic Test - Haemoglobin Diseases - Product Description 25
Hydrashift 2/4 Daratumumab Assay - Product Status 26
Hydrashift 2/4 Daratumumab Assay - Product Description 26
Sebia SA, Key Employees 28
Sebia SA, Subsidiaries 29
Glossary 34

List of Figures
Sebia SA Pipeline Products by Equipment Type 6
Sebia SA Pipeline Products by Development Stage 11

★海外企業調査レポート[Sebia SA:企業の製品パイプライン分析2018]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Promimic AB-医療機器分野:企業M&A・提携分析
    Summary Promimic AB (Promimic) is a biomaterial company that develops and markets implant surface modifications and synthetic bones. The company’s products comprise metals, ceramics, polymers, porous materials and pyrocarbon. Its HA-nano surface is a coating based on nanocrystalline hydroxyapatite p …
  • Mitsubishi Motors Corporation (7211):企業の財務・戦略的SWOT分析
    Mitsubishi Motors Corporation (7211) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Schreiber Foods, Inc.:企業の戦略・SWOT・財務情報
    Schreiber Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Schreiber Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Empire Co Ltd:企業の戦略・SWOT・財務情報
    Empire Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Empire Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Aeroports de Paris SA:戦略・SWOT・企業財務分析
    Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report Summary Aeroports de Paris SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • AccorHotels:戦略・SWOT・企業財務分析
    AccorHotels - Strategy, SWOT and Corporate Finance Report Summary AccorHotels - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Exandal Corp:企業の戦略・SWOT・財務分析
    Exandal Corp - Strategy, SWOT and Corporate Finance Report Summary Exandal Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Intercept Pharmaceuticals Inc (ICPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Intercept Pharmaceuticals Inc (Intercept) is a biopharmaceutical company that researches, develops and commercializes treatments for non-viral, progressive liver diseases. It develops products using its proprietary bile acid chemistry. The company’s lead product candidate, obeticholic acid ( …
  • Occidental Petroleum Corporation (OXY)-エネルギー分野:企業M&A・提携分析
    Summary Occidental Petroleum Corporation (Occidental) is an oil and gas exploration and production company with integrated assets. The company is active in upstream exploration and production; midstream and marketing; and chemicals business. The oil and gas business explores for, develops and produc …
  • Merus NV (MRUS):企業の財務・戦略的SWOT分析
    Summary Merus NV (Merus) discovers and develops antibody therapeutics for cancer indications. The company is investigating MCLA-128, for the treatment of metastatic breast cancer and solid tumors; MCLA-117 designed to harness and activate T-cells to kill CLEC12A-expressing acute myeloid leukemia (AM …
  • TechnipFMC Plc (FTI):企業の財務・戦略的SWOT分析
    TechnipFMC Plc (FTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Gibson Energy Inc (GEI):企業の財務・戦略的SWOT分析
    Gibson Energy Inc (GEI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Panoramic Universal Limited
    Panoramic Universal Limited - Strategy, SWOT and Corporate Finance Report Summary Panoramic Universal Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Bajaj Finance Ltd (BAJFINANCE):企業の財務・戦略的SWOT分析
    Bajaj Finance Ltd (BAJFINANCE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • The Lubrizol Corp:企業の戦略的SWOT分析
    The Lubrizol Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • TauRx Pharmaceuticals Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary TauRx Pharmaceuticals Ltd (TauRx) discovers, develops and commercializes treatments and diagnostics for Alzheimer's disease and other neurodegenerative diseases. Its pipeline products include LMTX, a tau aggregation inhibitor (TAI) for Alzheimer’s and Behavioural variant frontotemporal demen …
  • Genesis Healthcare, Inc.:戦略・SWOT・企業財務分析
    Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genesis Healthcare, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Oman Oil Co SAOC:石油・ガス:M&Aディール及び事業提携情報
    Summary Oman Oil Company SAOC (Oman Oil Company) is an oil and gas service provider that offers investment facilities for the growth and development of energy sector. The association invests and develops the areas of production, exploration, and related services, energy infrastructure and shipping, …
  • Biotronik SE & Co KG:企業の戦略的SWOT分析
    Biotronik SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Sotera Wireless Inc:医療機器:M&Aディール及び事業提携情報
    Summary Sotera Wireless Inc (Sotera Wireless) is a medical device company that provides technology products. The company develops and markets vital signs monitoring systems, ViSi Mobile systems, mobile monitor systems, and others. Its ViSi Mobile System is a platform for comprehensive vital signs mo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆